During the past decade, Retinal Consultants of Arizona conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retinal Consultants of Arizona" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Retinal Consultants of Arizona" are "Macular Degeneration" (2 trials), "Neovascular Age Related Macular Degeneration" (1 trials) and "Neovascular Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Retinal Consultants of Arizona" in a lesser frequency.

Most popular intervention types in "Retinal Consultants of Arizona" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abicipar Pegol" (1 trials), "Abicipar pegol" (1 trials), "Aflibercept" (1 trials), "GB-102" (1 trials) and "Lucentis (Treat and extend)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retinal Consultants of Arizona" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Retinal Consultants of Arizona". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Retinal Consultants of Arizona, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Retinal Consultants of Arizona, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".